Trial Profile
Efficacy of Liraglutide to Reduces the Need of Frequent Self Blood Glucose Monitoring in Both Insulin and Oral Agents Treated Patients with Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 10 Apr 2015 New trial record